The effect of parenteral nutrition on ICU patients

The effect of personalized parenteral nutrition on Intensive care unit (ICU) patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20151226025699N4

Enrollment

Registered

2020-06-03

Start date

2020-06-04

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal hemorrhage. Gastrointestinal hemorrhage, unspecified

Interventions

Intervention 1: After the gain of real weight and evaluation of disease status and chemistry results, the amount of required calorie will be estimated according to the ASPEN guidelines and then, the a

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Consent to participation Need to parenteral nutrition At least 24-h of hospitalization

Exclusion criteria

Exclusion criteria: Having no indication for parenteral nutrition for more than 1 week Unstable hemodynamic conditions

Design outcomes

Primary

Measure	Time frame
Urea. Timepoint: Baseline, 14-day after intervention. Method of measurement: using standard kits and the researchers gather these information from the lab test section of the ICU sheets.;Creatinine. Timepoint: Baseline, 14-day after intervention. Method of measurement: using standard kits and the researchers gather these information from the lab test section of the ICU sheets.;C reactive protein (CRP). Timepoint: Baseline, 14-day after intervention. Method of measurement: using standard kits and the researchers gather these information from the lab test section of the ICU sheets.;Serum albumin. Timepoint: Baseline, 14-day after intervention. Method of measurement: using standard kits and the researchers gather these information from the lab test section of the ICU sheets.	—

Measure

Time frame

Urea. Timepoint: Baseline, 14-day after intervention. Method of measurement: using standard kits and the researchers gather these information from the lab test section of the ICU sheets.;Creatinine. Timepoint: Baseline, 14-day after intervention. Method of measurement: using standard kits and the researchers gather these information from the lab test section of the ICU sheets.;C reactive protein (CRP). Timepoint: Baseline, 14-day after intervention. Method of measurement: using standard kits and the researchers gather these information from the lab test section of the ICU sheets.;Serum albumin. Timepoint: Baseline, 14-day after intervention. Method of measurement: using standard kits and the researchers gather these information from the lab test section of the ICU sheets.

—

Secondary

Measure	Time frame
ICU hospitalization. Timepoint: Baseline, 14-day after intervention. Method of measurement: Patients documents.;Survival rate. Timepoint: During 14-day intervention. Method of measurement: Patients documents.;Weight. Timepoint: During 14-day intervention. Method of measurement: This anthropometric indicator will be gathered from the patients records.;Body mass index (BMI). Timepoint: During 14-day intervention. Method of measurement: This anthropometric indicator will be gathered from the patients records.;Malnutrition status. Timepoint: During 14-day intervention. Method of measurement: It will be evaluated by weight & BMI criteria and by the level of serum albumin. We also use the Nutritional Risk Screening (NRS 2002) criterion for more evaluation.	—

Measure

Time frame

ICU hospitalization. Timepoint: Baseline, 14-day after intervention. Method of measurement: Patients documents.;Survival rate. Timepoint: During 14-day intervention. Method of measurement: Patients documents.;Weight. Timepoint: During 14-day intervention. Method of measurement: This anthropometric indicator will be gathered from the patients records.;Body mass index (BMI). Timepoint: During 14-day intervention. Method of measurement: This anthropometric indicator will be gathered from the patients records.;Malnutrition status. Timepoint: During 14-day intervention. Method of measurement: It will be evaluated by weight & BMI criteria and by the level of serum albumin. We also use the Nutritional Risk Screening (NRS 2002) criterion for more evaluation.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPr. Mohammad Esmaeil Akbari

Shahid Beheshti University of Medical Sciences

me-akbari@sbmu.ac.ir021 22748001-2

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026